help button home button Am J Pathol ASIP MEMBERSHIP
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Originally published online as doi:10.2353/ajpath.2008.080238 on July 3, 2008

Published online before print July 3, 2008
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ajpath.2008.080238v1
173/2/442    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Favaro, E.
Right arrow Articles by Zanone, M. M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Favaro, E.
Right arrow Articles by Zanone, M. M.
(American Journal of Pathology. 2008;173:442-450.)
© 2008 American Society for Investigative Pathology
DOI: 10.2353/ajpath.2008.080238

Hyperglycemia Induces Apoptosis of Human Pancreatic Islet Endothelial Cells

Effects of Pravastatin on the Akt Survival Pathway

Enrica Favaro*, Ilaria Miceli*, Benedetta Bussolati*, Michel Schimitt-Ney{dagger}, Paolo Cavallo Perin*, Giovanni Camussi* and Maria M. Zanone*

From the Department of Internal Medicine* and the Molecular Biotechnology Center,{dagger} University of Torino, Torino, Italy

Pancreatic islet microendothelium and β cells exhibit an interdependent physical and functional relationship. In this study, we analyzed the effect of chronic hyperglycemia on human pancreatic islet microendothelial cells as well as the involvement of the phosphatidylinositol 3-kinase/Akt and nephrin pathways, interleukin-1β, and nitric oxide production. In addition, whether 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors can reverse the response to high-glucose conditions was investigated. Proliferation of purified islet microendothelial cells cultured under hyperglycemic conditions (28 mmol/L glucose) decreased compared to that of normoglycemic cells (from 12.7% after 2 days to 47.7% after 30 days, P < 0.05). In parallel, apoptosis progressively increased from 7% after 2 days to 79% after 30 days in high glucose (P < 0.05) concomitant with an early increase of caspase-3 activity. Intermittent hyperglycemia induced greater apoptosis than sustained hyperglycemia. Apoptosis was accompanied by a reduced p-Akt/Akt ratio and inhibition of nephrin tyrosine phosphorylation. Pravastatin (1 µmol/L) decreased apoptosis induced by high glucose or oxidized LDL and increased Akt phosphorylation. Hyperglycemia significantly increased the production of the proinflammatory cytokine interleukin-1β and stimulated the expression of inducible nitric oxide synthase and the production of nitric oxide, possibly relevant to β cell mass and function. Thus, chronic hyperglycemia reduces islet microendothelial cell survival by inhibiting the serine-threonine kinase Akt pathway, and the effect of pravastatin on this pathway represents a potential tool to improve islet vascularization and, indirectly, islet function.








HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the American Society for Investigative Pathology.